We found that GALNT7, an enzyme that controls the initiation step of protein glycosylation and transfer of N-acetylgalactosamine to serine and threonine amino acid residues [67], is repressed in late-stage tumours and is implicated in patient survival across cancers (Fig. 6h). Here, GALNT7 is linked to cancer.